Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border
- PMID: 3513642
- DOI: 10.4269/ajtmh.1986.35.246
Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border
Abstract
Three different regimens were compared for treatment of falciparum malaria in displaced Kampucheans living in encampments on the Thai-Kampuchean border in 1983: single dose 750 mg mefloquine, 1.5 g sulfadoxine, 75 mg pyrimethamine (MSP); 600 mg quinine 8-hourly for 3 days and 500 mg tetracycline 8-hourly for 7 days (Q3T7); or 600 mg quinine 8-hourly for 7 days and 500 mg tetracycline 8-hourly for 7 days (Q7T7). Radical cure rates were 98% (40/41) for MSP, 76% (32/42) for Q3T7 and 92% (33/36) for Q7T7. The criterion for treatment failure was reappearance of parasites by 35 days after commencement of treatment or no parasite clearance. Treatment failures comprised one case of reduction but no clearance of parasites (RII resistance) for MSP, 10 recrudescences (RI) for Q3T7 and 3 recrudescences (RI) for Q7T7. The radical cure rate for Q3T7 was significantly lower than that for MSP (P less than 0.01), whilst Q7T7 significantly from the other groups. Parasite clearance time was shorter (2.4 days) with MSP than with Q3T7 (3.5 days) and Q7T7 (3.3 days). There was little difference in side effects between the regimens, and tolerance was good. The MSP and Q7T7 regimens are both effective for treatment, but the single dose of MSP is much easier to manage than 7 days of quinine and tetracycline.
Similar articles
-
The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.Southeast Asian J Trop Med Public Health. 1987 Jun;18(2):223-5. Southeast Asian J Trop Med Public Health. 1987. PMID: 3313739 Clinical Trial.
-
Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.Lancet. 1981 Nov 14;2(8255):1066-9. doi: 10.1016/s0140-6736(81)91274-5. Lancet. 1981. PMID: 6118522 Clinical Trial.
-
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.Bull World Health Organ. 1985;63(3):603-9. Bull World Health Organ. 1985. PMID: 3899397 Free PMC article. Clinical Trial.
-
Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro.J Trop Med Hyg. 1988 Aug;91(4):205-11. J Trop Med Hyg. 1988. PMID: 3043009
-
The treatment and control of parasitic diseases.Rev Infect Dis. 1982 Jul-Aug;4(4):885-90. doi: 10.1093/4.4.885. Rev Infect Dis. 1982. PMID: 6812199 Review.
Cited by
-
The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006.Malar J. 2009 Jun 27;8:142. doi: 10.1186/1475-2875-8-142. Malar J. 2009. PMID: 19558695 Free PMC article.
-
pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia.Antimicrob Agents Chemother. 2003 Jan;47(1):87-94. doi: 10.1128/AAC.47.1.87-94.2003. Antimicrob Agents Chemother. 2003. PMID: 12499174 Free PMC article.
-
Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?Southeast Asian J Trop Med Public Health. 2001 Mar;32(1):57-63. Southeast Asian J Trop Med Public Health. 2001. PMID: 11485096 Free PMC article.
-
Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.Br J Clin Pharmacol. 1987 Apr;23(4):477-81. doi: 10.1111/j.1365-2125.1987.tb03079.x. Br J Clin Pharmacol. 1987. PMID: 3555581 Free PMC article.
-
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1993 Mar;45(3):430-75. doi: 10.2165/00003495-199345030-00009. Drugs. 1993. PMID: 7682911 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials